Διεθνείς Δημοσιεύσεις
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC.
Gilberto de Castro Jr, Naiyer A Rizvi, Peter Schmid, Konstantinos Syrigos, Claudio Martin, Nobuyuki Yamamoto, Ying Cheng, Vladimir Moiseyenko, Yvonne Summers, Ihor Vynnychenko, Sung Yong Lee, Maciej Bryl, Alona Zer, Mustafa Erman, Constanta Timcheva, Rajiv Raja, Kirsha Naicker, Urban Scheuring, Jill Walker, Helen Mann, Vikram Chand, Tony Mok | J Thorac Oncol. 2023
Combination lurbinectedin and doxorubicin versus physician’s choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial.
Santiago Ponce Aix, Tudor Eliade Ciuleanu, Alejandro Navarro, Sophie Cousin, Laura Bonanno, Egbert F Smit, Alberto Chiappori, Maria Eugenia Olmedo, Ildiko Horvath, Christian Grohé, Anna F Farago, José Antonio López-Vilariño, Martin Cullell-Young, Antonio Nieto, Noelia Vasco, Javier Gómez, Carmen Kahatt, Ali Zeaiter, Enric Carcereny, Jaromir Roubec, Konstantinos Syrigos, Gregory Lo, Isidoro Barneto, Anthony Pope, Amparo Sánchez, Joseph Kattan, Konstantinos Zarogoulidis, Cornelius F Waller, Helge Bischoff, Oscar Juan-Vidal, Niels Reinmuth, Manuel Dómine, Luis Paz-Ares
| Lancet Respir Med. 2023
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer.
Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, Delvys Rodriguez-Abreu, Jorge Alatorre-Alexander, Hans J M Smit, Jinming Yu, Konstantinos Syrigos, Elen Höglander, Monika Kaul, Jonathan Tolson, Youyou Hu, Hans Kristian Vollan, Thomas Newsom-Davis
| J Immunother Cancer 2022
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade.
Ioannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M Kluger, Konstantinos N Syrigos, Sarah Warren, Mark Gerstein, David L Rimm
| NPJ Precis Oncol.
2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.
Charilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, Eran Reiner, Maria Kosmidou, Ioanna Karanika, Vasileios Petrakis, George Adamis, Nikolaos K Gatselis, Archontoula Fragkou, Aggeliki Rapti, Eleonora Taddei, Ioannis Kalomenidis, George Chrysos, Giulia Bertoli, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Evangelos Kostis, Lorenzo Dagna, Sofia Koukidou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Christina Trakatelli, George Tsoukalas, Carlo Selmi, Michael Samarkos, Athina Pyrpasopoulou, Aikaterini Masgala, Emmanouil Antonakis, Aikaterini Argyraki, Karolina Akinosoglou, Styliani Sympardi, Periklis Panagopoulos, Haralampos Milionis, Simeon Metallidis, Konstantinos N Syrigos, Alon Angel, George N Dalekos, Mihai G Netea, Evangelos J Giamarellos-Bourboulis
| Cytokine 2023
Baseline Ang-2 Serum Levels as a Predictive Factor for Survival in NSCLC and SCLC.
Asimina Nikolakopoulou, Dimitris Tsakogiannis, Flora Zagouri, Eleni Zografos, Lamprini Tzioga, Grigorios Stratakos, Nikolaos Koulouris, Konstantinos Syrigos, Garyfalia Bletsa
| Life (Basel)
2022
Prolonged SARS-CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 Therapy.
Amalia Papanikolopoulou, Vasilis Thimis, Eirini Antonogiannaki, Vasiliki Rapti, Konstantinos Tsiakos, Giannis Krallis, Sofia Ntouraki, Georgios Kokkotis Emmanouil Panagiotou, Vissaria Sakka, Eleni Kakalou, Thomas Nitsotolis, Garyphallia Poulakou, Konstantinos N Syrigos
| In Vivo 2023
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline.
A Falanga, C Ay, M Di Nisio, G Gerotziafas, L Jara-Palomares, F Langer, R Lecumberri, M Mandala, A Maraveyas, I Pabinger, M Sinn, K Syrigos, A Young, K Jordan
| Ann Oncol. 2023
Non-coding RNAs regulate mitochondrial dynamics in the development of gastric cancer.
Xiatian Chen, Chuang Wei, Liting Huang, Konstantinos Syrigos, Yuzhen Li, Peifeng Li
| Front Mol Biosci. 2023
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece.
Helena C Maltezou, Dimitrios Basoulis, Konstantinos Bonelis, Maria N Gamaletsou, Theodoros V Giannouchos, Eleni Karantoni, Αmalia Karapanou, Konstantinos Kounouklas, Maria Effrosyni Livanou, Maria Zotou, Vasiliki Rapti, Panagiota Stamou, Dimitrios Loulakis, Kyriakos Souliotis, Maria Chini, Periklis Panagopoulos, Garyfalia Poulakou, Konstantinos N Syrigos, Dimitrios Hatzigeorgiou, Nikolaos V Sipsas
| Vaccine 2023
Evolving Treatment Landscape of HER2-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond.
Ioannis A Vathiotis, Dimitrios Bafaloukos, Konstantinos N Syrigos, George Samonis
| Cancers (Basel) 2023
Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19.
Evdoxia Kyriazopoulou, Konstantinos Leventogiannis, Georgios Tavoulareas, Efstratios Mainas, Konstantinos Toutouzas, Christos Mathas, Athanassios Prekates, Vissaria Sakka, Periklis Panagopoulos, Konstantinos Syrigos, Evangelos J Giamarellos-Bourboulis
| Sci Rep. 2023
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’.
Giannis Mountzios, Anna Koumarianou, Helena Linardou, Anastasios Boutis, Dimitrios Mavroudis, Epaminondas Samantas, Ippokratis Korantzis, Elias Athanasiadis, Evangelos G Fergadis, Sofia Lampaki, Vassilis Georgoulias, Sofia Baka, Michalis V Karamouzis, Ioannis Boukovinas, Charalampos Andreadis, Aggeliki Rapti, Nikolaos Koulouris, George Pentheroudakis, Marios E Froudarakis, Alvertos Somarakis, Eleftheria Anastasopoulou, Alexandra Karadimou, Foteini Papageorgiou, Zoe Paparepa, Aristeidis Nikolaou, Christina Papista, Konstantinos N Syrigos
| Anticancer Res. 2023
Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece.
Vasiliki Rapti, Maria-Effrosyni Livanou, Anastasios Kollias, Tilemachos Koutouratsas, Orestis Savranakis, Vissaria Sakka, Thomas Nitsotolis, Eleni Kakalou, Kalomoira Athanasiou, Konstantinos N Syrigos, Garyfallia Poulakou
| In Vivo 2023
Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases.
Ioannis P Trontzas, Ioannis A Vathiotis, Konstantinos G Kyriakoulis, Amalia Sofianidi, Zoi Spyropoulou, Andriani Charpidou, Elias A Kotteas, Konstantinos N Syrigos
| Cancers (Basel) 2023
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
Cristian Barrera, Germán Corredor, Vidya Sankar Viswanathan, Ruiwen Ding, Paula Toro, Pingfu Fu, Christina Buzzy, Cheng Lu, Priya Velu, Philipp Zens, Sabina Berezowska, Merzu Belete, David Balli, Han Chang, Vipul Baxi, Konstantinos Syrigos, David L Rimm, Vamsidhar Velcheti, Kurt Schalper, Eduardo Romero , Anant Madabhushi
| NPJ Precis Oncol. 2023